UPDATE: Stifel Nicolaus Initiates Henry Schein at Hold on Valuation
Stifel Nicolaus initiated coverage on Henry Schein (NASDAQ: HSIC) with a Hold rating.
Stifel Nicolaus commented, "Henry Schein's market share gains in N.A. dental and veterinary have outpaced that of Patterson, the company's biggest competitor. As a result, we believe Schein's premium valuation is well deserved. That said, for the stock to post 20% upside from current levels, Henry Schein would need to recapture a 20x NTM EPS multiple. The stock's peak multiple over the past three years is in the high teens."
Henry Schein closed at $82.23 on Wednesday.
Latest Ratings for HSIC
|Apr 2017||Craig-Hallum||Initiates Coverage On||Hold|
|Mar 2017||Deutsche Bank||Initiates Coverage On||Hold|
|Jan 2017||Gabelli & Co.||Upgrades||Hold||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.